Integrated Model of Cancer Control for Early Detection and Treatment in Adolescents and Young Adults Living With HIV: Protocol for a Cluster Randomized Controlled Trial
JMIR Research Protocols · 2025
DOI: 10.2196/68254 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Sanjana Batabyal und 11 weiteren Autor:innen. Beteiligte Einrichtung: Implenomics, Dover, DE, United States. Hauptthemen laut MEDLINE: HIV Infections, Early Detection of Cancer, Neoplasms. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Zambia has one of the highest prevalence rates of HIV among adolescents and young adults (AYA) living with HIV in sub-Saharan Africa, which accounts for half of all new HIV cases as of 2023. Compared to their peers who are not living with HIV, AYA living with HIV are more likely to develop cancer. The most frequently diagnosed cancers among AYA living with HIV in Zambia are cervical cancer, Kaposi sarcoma, and non-Hodgkin lymphoma. Premature cancer mortality among AYA living with HIV is driven by late-stage presentation and poor treatment adherence.
Objective
We aim to develop and test an integrated model of cancer control for AYA living with HIV that can be delivered as an embedded component in existing HIV treatment programs in primary care facilities and linked with specialized treatment at cancer centers.
Methods
We propose a cluster randomized controlled trial to compare the AYAHIV Role-Based Responsibilities for Oncology-Focused Workforce (ARROW) program with a one-time education campaign. The ARROW program consists of interventions at the individual, health care provider, and health system levels. Peer counselors will educate AYA living with HIV through one-on-one and group education sessions and offer care coordination and linkages with clinicians. The HIV and oncology workforce will receive collaborative education and training. The ARROW Health Care Collaborative will connect administrators and policy makers to address system-level barriers. The study will recruit AYA living with HIV between the ages of 15 and 39 years who have been on antiretroviral therapy for at least 6 months and are not pregnant; the cancer treatment cohort will enroll AYA living with HIV who have been diagnosed with cervical cancer, Kaposi sarcoma, or non-Hodgkin lymphoma in Lusaka, Zambia. Half of the 18 HIV facilities have been randomly assigned to a one-time educational campaign and the other half to the ARROW intervention. Participants in the cancer treatment cohort will be randomized into 1 of the 2 study arms. We will conduct economic evaluations to assess the cost-effectiveness of the ARROW program. We will use an intent-to-treat approach to test the hypothesis that AYA living with HIV in the ARROW program will have higher uptake of diagnostic services, increased adherence to treatment, and improved outcomes compared to those receiving one-time education.
Results
As of March 2025, early detection cohort recruitment concluded with 3442 participants and cancer treatment cohort enrollment is ongoing, with 105 participants thus far. Results pertaining to the 12-month end points will be available in early 2026.
Conclusions
If successful, the ARROW program will offer a model to improve cancer prevention, early diagnosis, and treatment through improved integration between HIV and cancer services. Furthermore, ARROW can provide a framework for implementing expanded services, such as survivorship care, for AYA living with HIV. International Registered Report Identifier (IRRID) DERR1-10.2196/68254
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Implenomics, Dover, DE, United States.
- Population Council, Lusaka, Zambia.
- Clinical and Radiation Oncology Society of Zambia (ZASCRO), Lusaka, Zambia.
- RTI International, Durham, United States.
ORCID-Profile: Sanjana Batabyal, Praveen Zirali, Sonja Hoover, Ronald Mungoni, Nachela Chelwa, Drosin Mulenga, Mildred Lusaka, Laura Nyblade, Madeleine Jones, Catherine Kasongo Mwaba, Michael Mbizvo, Sujha Subramanian
Förderung
- NCI NIH HHS
Zitieren
APA
Batabyal, S., Zirali, P., Hoover, S., Mungoni, R., Chelwa, N., Mulenga, D., Lusaka, M., Nyblade, L., Jones, M., Mwaba, C. K., Mbizvo, M., & Subramanian, S. (2025). Integrated Model of Cancer Control for Early Detection and Treatment in Adolescents and Young Adults Living With HIV: Protocol for a Cluster Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/68254
Vancouver
Batabyal S, Zirali P, Hoover S, Mungoni R, Chelwa N, Mulenga D, et al. Integrated Model of Cancer Control for Early Detection and Treatment in Adolescents and Young Adults Living With HIV: Protocol for a Cluster Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/68254
BibTeX
@article{Batabyal2025,
author = {Batabyal, Sanjana and Zirali, Praveen and Hoover, Sonja and Mungoni, Ronald and Chelwa, Nachela and Mulenga, Drosin and Lusaka, Mildred and Nyblade, Laura and Jones, Madeleine and Mwaba, Catherine Kasongo and Mbizvo, Michael and Subramanian, Sujha},
title = {Integrated Model of Cancer Control for Early Detection and Treatment in Adolescents and Young Adults Living With HIV: Protocol for a Cluster Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/68254}
}
EUVIMED